Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Pharmaceutical Statistics|June 17, 2014
Statistical considerations associated with a comprehensive regulatory framework to address the unmet need for new antibacterial therapiesAaron Dane, Jeffrey D WetheringtonEvolution; International Journal of Organic Evolution|June 2, 2017
BALANCING SELECTION IN A DESERT STREAM-DWELLING FISH, POECILIOPSIS MONACHARobert C Vrijenhoek, Edward Pfeiler, Jeffrey D WetheringtonEvolution; International Journal of Organic Evolution|June 1, 2017
A TEST OF THE SPONTANEOUS HETEROSIS HYPOTHESIS FOR UNISEXUAL VERTEBRATESJeffrey D Wetherington, Karen E Kotora, Robert C VrijenhoekAntimicrobial Agents and Chemotherapy|April 29, 2015
Challenges and solutions for clinical development of new antibacterial agents: results of a survey among pharmaceutical industry professionalsEsther Bettiol, Jeffrey D Wetherington, Nicola Schmitt, et al.Environmental Toxicology and Chemistry|November 5, 2005
An evaluation of logistic regression models for predicting amphipod toxicity from sediment chemistryJeffrey D Wetherington, Bruce H Stanley, Kathleen O Adams, et al.Evolution; International Journal of Organic Evolution|June 2, 2017
GENOTYPIC AND ENVIRONMENTAL COMPONENTS OF VARIATION IN GROWTH AND REPRODUCTION OF FISH HEMICLONES (POECILIOPSIS: POECILIIDAE)Jeffrey D Wetherington, Stephen C Weeks, Karen E Kotora, et al.Pharmaceutical Statistics|August 29, 2018
Phase 3 adaptive trial design options in treatment of complicated urinary tract infectionKert Viele, Linda M Mundy, Robert B Noble, et al.Mathematical and Computer Modelling|February 18, 2010
A Mathematical Model for the First-Pass Dynamics of Antibiotics Acting on the Cardiovascular SystemH T Banks, Kathleen Holm, Nathan C Wanner, et al.Journal of Clinical Pharmacology|October 1, 2010
Model-based drug development: strengths, weaknesses, opportunities, and threats for broad application of pharmacometrics in drug developmentJeffrey D Wetherington, Marc Pfister, Christopher Banfield, et al.Journal of Clinical Pharmacology|October 1, 2010
Model-based drug development survey finds pharmacometrics impacting decision making in the pharmaceutical industryJulie A Stone, Christopher Banfield, Marc Pfister, et al.Pageof 1